Mesangial Cell-Binding Anti-DNA Antibodies in Patients with Systemic Lupus Erythematosus
Authors:
- Tak-Mao ChanTCTak-Mao Chan
- Jack Kok-Hung LeungJLJack Kok-Hung Leung
- Stephen Kar-Nung HoSHStephen Kar-Nung Ho
- Susan YungSYSusan Yung
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 13 (5) , 1219-1229
Abstract
: The mechanisms by which anti-DNA antibodies contribute to the pathogenesis of lupus nephritis (LN) remain to be elucidated. This study investigates the binding of polyclonal anti-DNA immunoglobulins from patients with systemic lupus erythematosus (SLE) to human mesangial cells (HMC) in vitro. Testing of cross-sectional serum samples from 280 LN patients (108 during active disease; 172 during remission), 35 SLE patients without renal involvement, 72 patients with non-lupus primary glomerular diseases, and 37 healthy subjects with a cellular enzyme-linked immunosorbent assay showed significant IgG mesangial cell-binding activity in patients with SLE, particularly those with active LN (P < 0.0001). Significant HMC-binding activity was demonstrated in 83.9%, 42.8%, and 47.1% of patients with active LN, inactive LN, and non-renal SLE, respectively. This was predominantly attributed to binding by anti-DNA antibodies, and immune complex binding accounted for 4.6%, 3.5%, and 2.8% of seropositive samples in the respective groups. Longitudinal studies in 27 LN patients demonstrated correlation between serial levels of anti-DNA antibodies, serum HMC-binding activity, and disease activity in 18 patients (66.7%). Affinity-purified polyclonal IgG anti-DNA antibodies from sera with HMC-binding activity showed significant binding to cultured HMC, and to a lesser extent glomerular and proximal tubular epithelial cells and human umbilical vein endothelial cells, but not tumor cell lines, peritoneal mesothelial cells, bronchial epithelial cells, or fibroblasts. The binding of anti-DNA antibodies to HMC was increased 1.47-fold (P = 0.0059) after the removal of Ig-associated DNA by DNase treatment, but it was unaffected by DNase treatment of HMC membrane. Controlled trypsinization of membrane proteins in HMC resulted in a 1.26-fold (P = 0.0025) increase in their binding by anti-DNA antibodies. In conclusion, subsets of anti-DNA antibodies from patients with SLE are capable of binding to HMC. The association of such binding with renal involvement and disease activity and its modulation by DNA concentration suggest that Ig binding to HMC can be a potential marker for disease activity in selected patients and that the binding of anti-DNA antibodies to HMC may be a pathogenetic mechanism in LN.Keywords
This publication has 20 references indexed in Scilit:
- An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1996
- Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.Journal of Clinical Investigation, 1996
- Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigensKidney International, 1996
- Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells.Annals of the Rheumatic Diseases, 1992
- Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosusArthritis & Rheumatism, 1990
- Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humansArthritis & Rheumatism, 1989
- A murine nephritogenic monoclonal anti‐DNA autoantibody binds directly to mouse laminin, the major non‐collagenous protein component of the glomerular basement membraneEuropean Journal of Immunology, 1989
- Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodiesClinical Immunology and Immunopathology, 1984
- Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritisClinical Immunology and Immunopathology, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982